MATTHEW W FOEHR

CIK 1237556 · President and CEO · last filed 2026-04-07

MATTHEW W FOEHR is a President and CEO who has filed 134 SEC Form 4 insider transactions across 6 companies since 2011. The most recent filing, for OABI, was dated Apr 7, 2026. Across all open-market trades the lifetime net is −$24.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $53.0M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$53.00M

Companies

6

Total Filings

134

Lifetime Open-Market Net

-$24.19M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
OABIW	President and CEO	4,420,492	$0.08	$368.7K	$7.27M	33	2026-04-07
VKTX	Director	135,186	$33.86	$4.58M	-$286.7K	11	2026-01-05
LGND	President and COO	162,187	$296.28	$48.05M	-$31.25M	58	2022-11-03
Viking Therapeutics, Inc. (VKTXW) Delisted	Director	46,250	$4.60	$212.7K	-$79.9K	8	2021-03-25
Qualigen Therapeutics, Inc. (RTTR) Delisted	Director	5,545	—	—	$133.1K	12	2020-04-23
Viking Therapeutics, Inc. (VKTX.W) Delisted	Director	26,250	—	—	$24.8K	1	2016-04-13

Recent Filings

134 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2026-04-07	OABI	Notice (144)	−19,244	-$28.6K	EDGAR
2026-04-07	OABIW	Mixed	+17,215	-$28.7K	EDGAR
2026-02-18	OABIW	Mixed	+27,490	-$52.7K	EDGAR
2026-02-17	OABI	Notice (144)	−20,483	-$34.8K	EDGAR
2026-02-17	OABIW	Mixed	+15,704	-$35.3K	EDGAR
2026-01-05	VKTX	Mixed	+3,150	-$508.4K	EDGAR
2026-01-02	VKTX	Notice (144)	−16,000	-$561.7K	EDGAR
2025-12-09	OABIW	Mixed	+12,888	-$26.8K	EDGAR
2025-12-08	OABI	Notice (144)	−13,666	-$26.8K	EDGAR
2025-08-26	OABIW	Grant (A)	+540,540	$1000.0K	EDGAR

Showing 1–10 of 134

Page 1 of 14 Next

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.